Skip to main content

CF-301 Phase III

Clinical Trial Grant
Duke Scholars

Awarded By

ContraFect Corporation

Start Date

November 15, 2019

End Date

January 31, 2023
 

Awarded By

ContraFect Corporation

Start Date

November 15, 2019

End Date

January 31, 2023